A
Active Iron
Healthcare development company focused on optimizing established therapies through innovative science
About Active Iron
Solvotrin Therapeutics is a privately held Irish healthcare and medicine development company focused on optimizing established therapies, vitamins, and minerals using innovative science to address significant unmet clinical needs. The company operates in the life sciences and pharmaceutical market, targeting both healthcare providers and patients who require improved therapeutic options. Solvotrin's business model revolves around research and development, creating proprietary formulations that enhance the effectiveness and tolerance of existing treatments, such as iron and aspirin. Revenue is generated through product sales, partnerships, and licensing agreements with major pharmaceutical companies. The company has successfully launched products like Active Iron and is expanding its market reach into Europe and China through strategic partnerships. Solvotrin's commitment to innovation and clinical excellence positions it as a key player in the healthcare industry.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Cork, Ireland
- Employees
- 20
- Open positions
- None listed
- Dealroom signal
- 69.1/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Health Care Information Technology, Dietary Supplements, Biotechnology, Oncology, Drug Development, Health and Wellness, Superfood, Chemistry
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Nov 2020 | $7.4M | $50M | RAB Capital · Elkstone Capital Partners | — |
| EARLY VC✓Equity / VC | Feb 2017 | $2.2M | $8.8M | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Active Iron is 33K monthly website visits, down 45.9% over the last three months. Active Iron's team declined 13% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
RAB Capital
Elkstone Capital Partners
Other known investors1 additional known investor
Trinity College Dublin
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Active Iron on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Active Iron’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.